GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » PB Ratio

Kyorin Pharmaceutical Co (TSE:4569) PB Ratio : 0.78 (As of May. 21, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), Kyorin Pharmaceutical Co's share price is 円1714.00. Kyorin Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2023 was 円2,208.84. Hence, Kyorin Pharmaceutical Co's PB Ratio of today is 0.78.

Good Sign:

Kyorin Pharmaceutical Co Ltd stock PB Ratio (=0.78) is close to 10-year low of 0.74

The historical rank and industry rank for Kyorin Pharmaceutical Co's PB Ratio or its related term are showing as below:

TSE:4569' s PB Ratio Range Over the Past 10 Years
Min: 0.74   Med: 0.97   Max: 1.53
Current: 0.78

During the past 13 years, Kyorin Pharmaceutical Co's highest PB Ratio was 1.53. The lowest was 0.74. And the median was 0.97.

TSE:4569's PB Ratio is ranked better than
87.02% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2.02 vs TSE:4569: 0.78

During the past 12 months, Kyorin Pharmaceutical Co's average Book Value Per Share Growth Rate was -0.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 0.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 1.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Kyorin Pharmaceutical Co was 8.30% per year. The lowest was -0.60% per year. And the median was 3.10% per year.

Back to Basics: PB Ratio


Kyorin Pharmaceutical Co PB Ratio Historical Data

The historical data trend for Kyorin Pharmaceutical Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co PB Ratio Chart

Kyorin Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 1.03 0.89 0.82 0.78

Kyorin Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.78 0.80 0.83 0.81

Competitive Comparison of Kyorin Pharmaceutical Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kyorin Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyorin Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyorin Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Kyorin Pharmaceutical Co's PB Ratio falls into.



Kyorin Pharmaceutical Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Kyorin Pharmaceutical Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1714.00/2208.837
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Kyorin Pharmaceutical Co  (TSE:4569) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Kyorin Pharmaceutical Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyorin Pharmaceutical Co (TSE:4569) Business Description

Traded in Other Exchanges
N/A
Address
6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co (TSE:4569) Headlines

No Headlines